Mutant p53 enhances MET trafficking and signalling to drive cell scattering and invasion

Tumour-derived mutant p53 proteins promote invasion, in part, by enhancing Rab coupling protein (RCP)-dependent receptor recycling. Here we identified MET as an RCP-binding protein and showed that mutant p53 promoted MET recycling. Mutant p53-expressing cells were more sensitive to hepatocyte growth...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncogene 2013-03, Vol.32 (10), p.1252-1265
Hauptverfasser: Muller, P A J, Trinidad, A G, Timpson, P, Morton, J P, Zanivan, S, van den Berghe, P V E, Nixon, C, Karim, S A, Caswell, P T, Noll, J E, Coffill, C R, Lane, D P, Sansom, O J, Neilsen, P M, Norman, J C, Vousden, K H
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1265
container_issue 10
container_start_page 1252
container_title Oncogene
container_volume 32
creator Muller, P A J
Trinidad, A G
Timpson, P
Morton, J P
Zanivan, S
van den Berghe, P V E
Nixon, C
Karim, S A
Caswell, P T
Noll, J E
Coffill, C R
Lane, D P
Sansom, O J
Neilsen, P M
Norman, J C
Vousden, K H
description Tumour-derived mutant p53 proteins promote invasion, in part, by enhancing Rab coupling protein (RCP)-dependent receptor recycling. Here we identified MET as an RCP-binding protein and showed that mutant p53 promoted MET recycling. Mutant p53-expressing cells were more sensitive to hepatocyte growth factor, the ligand for MET, leading to enhanced MET signalling, invasion and cell scattering that was dependent on both MET and RCP. In cells expressing the p53 family member TAp63, inhibition of TAp63 also lead to cell scattering and MET-dependent invasion. However, in cells that express very low levels of TAp63, the ability of mutant p53 to promote MET-dependent cell scattering was independent of TAp63. Taken together, our data show that mutant p53 can enhance MET signalling to promote cell scattering and invasion through both TAp63-dependent and -independent mechanisms. MET has a predominant role in metastatic progression and the identification of mechanisms through which mutations in p53 can drive MET signalling may help to identify and direct therapy.
doi_str_mv 10.1038/onc.2012.148
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3592945</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A322563690</galeid><sourcerecordid>A322563690</sourcerecordid><originalsourceid>FETCH-LOGICAL-c550t-24eaa9bfad4b7e51e22fa8991c10a253d70515ca180250e85ce9c21a483e4ab3</originalsourceid><addsrcrecordid>eNqNkstv1DAQxiMEokvhxhlF4sKBLONXEl-Qqqo8pFZc9sDNmnUmW5esvdjJSv3vcdi22qIekA-Wx7_5NI-vKN4yWDIQ7afg7ZID40sm22fFgsmmrpTS8nmxAK2g0lzwk-JVSjcA0GjgL4sTzlULNbBF8fNqGtGP5U6Jkvw1ekupvLpYlWPEvnf2l_ObEn1XJrfxOAzzcwxlF92eSkvDUCaL40jxnnN-j8kF_7p40eOQ6M3dfVqsvlyszr9Vlz--fj8_u6ysUjBWXBKiXvfYyXVDihHnPbZaM8sAuRJdA4opi6wFroBaZUlbzlC2giSuxWnx-SC7m9Zb6iz5XPhgdtFtMd6agM48_vHu2mzC3giluZYqC3y4E4jh90RpNFuX5sbQU5iSYYKLFljdsP9Amaq55rLJ6Pt_0JswxTzAv5TUteBwRG1wION8H3KJdhY1ZyLvqBa1hkwtn6Dy6WjrbPDUuxx_lPDxkGBjSClS_zAOBmb2jMmeMbNnTPZMxt8dj_ABvjdJBqoDkHbzmikeNfOU4B9uw8m7</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1314963207</pqid></control><display><type>article</type><title>Mutant p53 enhances MET trafficking and signalling to drive cell scattering and invasion</title><source>MEDLINE</source><source>Nature Journals Online</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>SpringerLink Journals - AutoHoldings</source><creator>Muller, P A J ; Trinidad, A G ; Timpson, P ; Morton, J P ; Zanivan, S ; van den Berghe, P V E ; Nixon, C ; Karim, S A ; Caswell, P T ; Noll, J E ; Coffill, C R ; Lane, D P ; Sansom, O J ; Neilsen, P M ; Norman, J C ; Vousden, K H</creator><creatorcontrib>Muller, P A J ; Trinidad, A G ; Timpson, P ; Morton, J P ; Zanivan, S ; van den Berghe, P V E ; Nixon, C ; Karim, S A ; Caswell, P T ; Noll, J E ; Coffill, C R ; Lane, D P ; Sansom, O J ; Neilsen, P M ; Norman, J C ; Vousden, K H</creatorcontrib><description>Tumour-derived mutant p53 proteins promote invasion, in part, by enhancing Rab coupling protein (RCP)-dependent receptor recycling. Here we identified MET as an RCP-binding protein and showed that mutant p53 promoted MET recycling. Mutant p53-expressing cells were more sensitive to hepatocyte growth factor, the ligand for MET, leading to enhanced MET signalling, invasion and cell scattering that was dependent on both MET and RCP. In cells expressing the p53 family member TAp63, inhibition of TAp63 also lead to cell scattering and MET-dependent invasion. However, in cells that express very low levels of TAp63, the ability of mutant p53 to promote MET-dependent cell scattering was independent of TAp63. Taken together, our data show that mutant p53 can enhance MET signalling to promote cell scattering and invasion through both TAp63-dependent and -independent mechanisms. MET has a predominant role in metastatic progression and the identification of mechanisms through which mutations in p53 can drive MET signalling may help to identify and direct therapy.</description><identifier>ISSN: 0950-9232</identifier><identifier>ISSN: 1476-5594</identifier><identifier>EISSN: 1476-5594</identifier><identifier>DOI: 10.1038/onc.2012.148</identifier><identifier>PMID: 22580601</identifier><identifier>CODEN: ONCNES</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>631/67/322 ; 631/80/84/2336 ; 631/80/86 ; Animals ; Apoptosis ; Cancer cells ; Carcinoma, Non-Small-Cell Lung - genetics ; Carcinoma, Non-Small-Cell Lung - metabolism ; Carcinoma, Non-Small-Cell Lung - pathology ; Cell adhesion &amp; migration ; Cell Biology ; Cell Movement ; Colonic Neoplasms - genetics ; Colonic Neoplasms - metabolism ; Colonic Neoplasms - pathology ; HCT116 Cells ; HT29 Cells ; Human Genetics ; Humans ; Internal Medicine ; Lung Neoplasms - genetics ; Lung Neoplasms - metabolism ; Lung Neoplasms - pathology ; Medicine ; Medicine &amp; Public Health ; Metastasis ; Mice ; Mutation ; Neoplasm Invasiveness ; Oncology ; Original ; original-article ; Phosphorylation ; Proteins ; Proto-Oncogene Proteins c-met - genetics ; Proto-Oncogene Proteins c-met - metabolism ; Signal Transduction ; Transcription Factors - metabolism ; Transfection ; Tumor proteins ; Tumor Suppressor Protein p53 - genetics ; Tumor Suppressor Protein p53 - metabolism ; Tumor Suppressor Proteins - metabolism ; Tumors</subject><ispartof>Oncogene, 2013-03, Vol.32 (10), p.1252-1265</ispartof><rights>The Author(s) 2013</rights><rights>COPYRIGHT 2013 Nature Publishing Group</rights><rights>Copyright Nature Publishing Group Mar 7, 2013</rights><rights>Copyright © 2013 Macmillan Publishers Limited 2013 Macmillan Publishers Limited</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c550t-24eaa9bfad4b7e51e22fa8991c10a253d70515ca180250e85ce9c21a483e4ab3</citedby><cites>FETCH-LOGICAL-c550t-24eaa9bfad4b7e51e22fa8991c10a253d70515ca180250e85ce9c21a483e4ab3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/onc.2012.148$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/onc.2012.148$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22580601$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Muller, P A J</creatorcontrib><creatorcontrib>Trinidad, A G</creatorcontrib><creatorcontrib>Timpson, P</creatorcontrib><creatorcontrib>Morton, J P</creatorcontrib><creatorcontrib>Zanivan, S</creatorcontrib><creatorcontrib>van den Berghe, P V E</creatorcontrib><creatorcontrib>Nixon, C</creatorcontrib><creatorcontrib>Karim, S A</creatorcontrib><creatorcontrib>Caswell, P T</creatorcontrib><creatorcontrib>Noll, J E</creatorcontrib><creatorcontrib>Coffill, C R</creatorcontrib><creatorcontrib>Lane, D P</creatorcontrib><creatorcontrib>Sansom, O J</creatorcontrib><creatorcontrib>Neilsen, P M</creatorcontrib><creatorcontrib>Norman, J C</creatorcontrib><creatorcontrib>Vousden, K H</creatorcontrib><title>Mutant p53 enhances MET trafficking and signalling to drive cell scattering and invasion</title><title>Oncogene</title><addtitle>Oncogene</addtitle><addtitle>Oncogene</addtitle><description>Tumour-derived mutant p53 proteins promote invasion, in part, by enhancing Rab coupling protein (RCP)-dependent receptor recycling. Here we identified MET as an RCP-binding protein and showed that mutant p53 promoted MET recycling. Mutant p53-expressing cells were more sensitive to hepatocyte growth factor, the ligand for MET, leading to enhanced MET signalling, invasion and cell scattering that was dependent on both MET and RCP. In cells expressing the p53 family member TAp63, inhibition of TAp63 also lead to cell scattering and MET-dependent invasion. However, in cells that express very low levels of TAp63, the ability of mutant p53 to promote MET-dependent cell scattering was independent of TAp63. Taken together, our data show that mutant p53 can enhance MET signalling to promote cell scattering and invasion through both TAp63-dependent and -independent mechanisms. MET has a predominant role in metastatic progression and the identification of mechanisms through which mutations in p53 can drive MET signalling may help to identify and direct therapy.</description><subject>631/67/322</subject><subject>631/80/84/2336</subject><subject>631/80/86</subject><subject>Animals</subject><subject>Apoptosis</subject><subject>Cancer cells</subject><subject>Carcinoma, Non-Small-Cell Lung - genetics</subject><subject>Carcinoma, Non-Small-Cell Lung - metabolism</subject><subject>Carcinoma, Non-Small-Cell Lung - pathology</subject><subject>Cell adhesion &amp; migration</subject><subject>Cell Biology</subject><subject>Cell Movement</subject><subject>Colonic Neoplasms - genetics</subject><subject>Colonic Neoplasms - metabolism</subject><subject>Colonic Neoplasms - pathology</subject><subject>HCT116 Cells</subject><subject>HT29 Cells</subject><subject>Human Genetics</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Lung Neoplasms - genetics</subject><subject>Lung Neoplasms - metabolism</subject><subject>Lung Neoplasms - pathology</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Metastasis</subject><subject>Mice</subject><subject>Mutation</subject><subject>Neoplasm Invasiveness</subject><subject>Oncology</subject><subject>Original</subject><subject>original-article</subject><subject>Phosphorylation</subject><subject>Proteins</subject><subject>Proto-Oncogene Proteins c-met - genetics</subject><subject>Proto-Oncogene Proteins c-met - metabolism</subject><subject>Signal Transduction</subject><subject>Transcription Factors - metabolism</subject><subject>Transfection</subject><subject>Tumor proteins</subject><subject>Tumor Suppressor Protein p53 - genetics</subject><subject>Tumor Suppressor Protein p53 - metabolism</subject><subject>Tumor Suppressor Proteins - metabolism</subject><subject>Tumors</subject><issn>0950-9232</issn><issn>1476-5594</issn><issn>1476-5594</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqNkstv1DAQxiMEokvhxhlF4sKBLONXEl-Qqqo8pFZc9sDNmnUmW5esvdjJSv3vcdi22qIekA-Wx7_5NI-vKN4yWDIQ7afg7ZID40sm22fFgsmmrpTS8nmxAK2g0lzwk-JVSjcA0GjgL4sTzlULNbBF8fNqGtGP5U6Jkvw1ekupvLpYlWPEvnf2l_ObEn1XJrfxOAzzcwxlF92eSkvDUCaL40jxnnN-j8kF_7p40eOQ6M3dfVqsvlyszr9Vlz--fj8_u6ysUjBWXBKiXvfYyXVDihHnPbZaM8sAuRJdA4opi6wFroBaZUlbzlC2giSuxWnx-SC7m9Zb6iz5XPhgdtFtMd6agM48_vHu2mzC3giluZYqC3y4E4jh90RpNFuX5sbQU5iSYYKLFljdsP9Amaq55rLJ6Pt_0JswxTzAv5TUteBwRG1wION8H3KJdhY1ZyLvqBa1hkwtn6Dy6WjrbPDUuxx_lPDxkGBjSClS_zAOBmb2jMmeMbNnTPZMxt8dj_ABvjdJBqoDkHbzmikeNfOU4B9uw8m7</recordid><startdate>20130307</startdate><enddate>20130307</enddate><creator>Muller, P A J</creator><creator>Trinidad, A G</creator><creator>Timpson, P</creator><creator>Morton, J P</creator><creator>Zanivan, S</creator><creator>van den Berghe, P V E</creator><creator>Nixon, C</creator><creator>Karim, S A</creator><creator>Caswell, P T</creator><creator>Noll, J E</creator><creator>Coffill, C R</creator><creator>Lane, D P</creator><creator>Sansom, O J</creator><creator>Neilsen, P M</creator><creator>Norman, J C</creator><creator>Vousden, K H</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20130307</creationdate><title>Mutant p53 enhances MET trafficking and signalling to drive cell scattering and invasion</title><author>Muller, P A J ; Trinidad, A G ; Timpson, P ; Morton, J P ; Zanivan, S ; van den Berghe, P V E ; Nixon, C ; Karim, S A ; Caswell, P T ; Noll, J E ; Coffill, C R ; Lane, D P ; Sansom, O J ; Neilsen, P M ; Norman, J C ; Vousden, K H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c550t-24eaa9bfad4b7e51e22fa8991c10a253d70515ca180250e85ce9c21a483e4ab3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>631/67/322</topic><topic>631/80/84/2336</topic><topic>631/80/86</topic><topic>Animals</topic><topic>Apoptosis</topic><topic>Cancer cells</topic><topic>Carcinoma, Non-Small-Cell Lung - genetics</topic><topic>Carcinoma, Non-Small-Cell Lung - metabolism</topic><topic>Carcinoma, Non-Small-Cell Lung - pathology</topic><topic>Cell adhesion &amp; migration</topic><topic>Cell Biology</topic><topic>Cell Movement</topic><topic>Colonic Neoplasms - genetics</topic><topic>Colonic Neoplasms - metabolism</topic><topic>Colonic Neoplasms - pathology</topic><topic>HCT116 Cells</topic><topic>HT29 Cells</topic><topic>Human Genetics</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Lung Neoplasms - genetics</topic><topic>Lung Neoplasms - metabolism</topic><topic>Lung Neoplasms - pathology</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Metastasis</topic><topic>Mice</topic><topic>Mutation</topic><topic>Neoplasm Invasiveness</topic><topic>Oncology</topic><topic>Original</topic><topic>original-article</topic><topic>Phosphorylation</topic><topic>Proteins</topic><topic>Proto-Oncogene Proteins c-met - genetics</topic><topic>Proto-Oncogene Proteins c-met - metabolism</topic><topic>Signal Transduction</topic><topic>Transcription Factors - metabolism</topic><topic>Transfection</topic><topic>Tumor proteins</topic><topic>Tumor Suppressor Protein p53 - genetics</topic><topic>Tumor Suppressor Protein p53 - metabolism</topic><topic>Tumor Suppressor Proteins - metabolism</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Muller, P A J</creatorcontrib><creatorcontrib>Trinidad, A G</creatorcontrib><creatorcontrib>Timpson, P</creatorcontrib><creatorcontrib>Morton, J P</creatorcontrib><creatorcontrib>Zanivan, S</creatorcontrib><creatorcontrib>van den Berghe, P V E</creatorcontrib><creatorcontrib>Nixon, C</creatorcontrib><creatorcontrib>Karim, S A</creatorcontrib><creatorcontrib>Caswell, P T</creatorcontrib><creatorcontrib>Noll, J E</creatorcontrib><creatorcontrib>Coffill, C R</creatorcontrib><creatorcontrib>Lane, D P</creatorcontrib><creatorcontrib>Sansom, O J</creatorcontrib><creatorcontrib>Neilsen, P M</creatorcontrib><creatorcontrib>Norman, J C</creatorcontrib><creatorcontrib>Vousden, K H</creatorcontrib><collection>Springer Nature OA/Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Oncogene</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Muller, P A J</au><au>Trinidad, A G</au><au>Timpson, P</au><au>Morton, J P</au><au>Zanivan, S</au><au>van den Berghe, P V E</au><au>Nixon, C</au><au>Karim, S A</au><au>Caswell, P T</au><au>Noll, J E</au><au>Coffill, C R</au><au>Lane, D P</au><au>Sansom, O J</au><au>Neilsen, P M</au><au>Norman, J C</au><au>Vousden, K H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mutant p53 enhances MET trafficking and signalling to drive cell scattering and invasion</atitle><jtitle>Oncogene</jtitle><stitle>Oncogene</stitle><addtitle>Oncogene</addtitle><date>2013-03-07</date><risdate>2013</risdate><volume>32</volume><issue>10</issue><spage>1252</spage><epage>1265</epage><pages>1252-1265</pages><issn>0950-9232</issn><issn>1476-5594</issn><eissn>1476-5594</eissn><coden>ONCNES</coden><abstract>Tumour-derived mutant p53 proteins promote invasion, in part, by enhancing Rab coupling protein (RCP)-dependent receptor recycling. Here we identified MET as an RCP-binding protein and showed that mutant p53 promoted MET recycling. Mutant p53-expressing cells were more sensitive to hepatocyte growth factor, the ligand for MET, leading to enhanced MET signalling, invasion and cell scattering that was dependent on both MET and RCP. In cells expressing the p53 family member TAp63, inhibition of TAp63 also lead to cell scattering and MET-dependent invasion. However, in cells that express very low levels of TAp63, the ability of mutant p53 to promote MET-dependent cell scattering was independent of TAp63. Taken together, our data show that mutant p53 can enhance MET signalling to promote cell scattering and invasion through both TAp63-dependent and -independent mechanisms. MET has a predominant role in metastatic progression and the identification of mechanisms through which mutations in p53 can drive MET signalling may help to identify and direct therapy.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>22580601</pmid><doi>10.1038/onc.2012.148</doi><tpages>14</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0950-9232
ispartof Oncogene, 2013-03, Vol.32 (10), p.1252-1265
issn 0950-9232
1476-5594
1476-5594
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3592945
source MEDLINE; Nature Journals Online; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; SpringerLink Journals - AutoHoldings
subjects 631/67/322
631/80/84/2336
631/80/86
Animals
Apoptosis
Cancer cells
Carcinoma, Non-Small-Cell Lung - genetics
Carcinoma, Non-Small-Cell Lung - metabolism
Carcinoma, Non-Small-Cell Lung - pathology
Cell adhesion & migration
Cell Biology
Cell Movement
Colonic Neoplasms - genetics
Colonic Neoplasms - metabolism
Colonic Neoplasms - pathology
HCT116 Cells
HT29 Cells
Human Genetics
Humans
Internal Medicine
Lung Neoplasms - genetics
Lung Neoplasms - metabolism
Lung Neoplasms - pathology
Medicine
Medicine & Public Health
Metastasis
Mice
Mutation
Neoplasm Invasiveness
Oncology
Original
original-article
Phosphorylation
Proteins
Proto-Oncogene Proteins c-met - genetics
Proto-Oncogene Proteins c-met - metabolism
Signal Transduction
Transcription Factors - metabolism
Transfection
Tumor proteins
Tumor Suppressor Protein p53 - genetics
Tumor Suppressor Protein p53 - metabolism
Tumor Suppressor Proteins - metabolism
Tumors
title Mutant p53 enhances MET trafficking and signalling to drive cell scattering and invasion
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T17%3A29%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mutant%20p53%20enhances%20MET%20trafficking%20and%20signalling%20to%20drive%20cell%20scattering%20and%20invasion&rft.jtitle=Oncogene&rft.au=Muller,%20P%20A%20J&rft.date=2013-03-07&rft.volume=32&rft.issue=10&rft.spage=1252&rft.epage=1265&rft.pages=1252-1265&rft.issn=0950-9232&rft.eissn=1476-5594&rft.coden=ONCNES&rft_id=info:doi/10.1038/onc.2012.148&rft_dat=%3Cgale_pubme%3EA322563690%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1314963207&rft_id=info:pmid/22580601&rft_galeid=A322563690&rfr_iscdi=true